Download FREE Report Sample
Download Free sampleErythropoietin (EPO), also known as haematopoietin or haemopoietin, is a glycoprotein cytokine secreted by the kidney in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow. Low levels of EPO (around 10 mU/mL) are constantly secreted sufficient to compensate for normal red blood cell turnover. Common causes of cellular hypoxia resulting in elevated levels of EPO (up to 10 000 mU/mL) include any anemia, and hypoxemia due to chronic lung disease.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. Liver production predominates in the fetal and perinatal period; renal production predominates in adulthood. It is homologous with thrombopoietin.
Recombinant Erythropoietin Drugs Market contains market size and forecasts of Recombinant Erythropoietin Drugs in global, including the following market information:
Global Recombinant Erythropoietin Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Erythropoietin Drugs Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Recombinant Erythropoietin Drugs companies in 2021 (%)
The global Recombinant Erythropoietin Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
rhEPO Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Erythropoietin Drugs include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Roche, 3SBio Group, Celltrion, Inc, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd and LG Life Sciences Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Erythropoietin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Erythropoietin Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, by Type, 2021 (%)
Global Recombinant Erythropoietin Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, by Application, 2021 (%)
Global Recombinant Erythropoietin Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Erythropoietin Drugs Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
